Fortrea Holdings Inc. (FTRE) - Stock Analysis
Last updated: Apr 4, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Fortrea displays strong operational momentum with raised revenue and backlog, cost savings, debt reductions, and a significant 50% rally in 3 weeks; however, margin compression, leverage, legal risk, and overextension temper conviction, requiring active risk management.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Positive free cashflow ⢠High leverage ⢠Negative net margins Despite strong gross margins and positive free cash flow, FTRE remains unprofitable with heavy OPEX-driven losses, high leverage and tight liquidity that materially raise risk even as quarterly EBITDA improves.
Price Behavior
Key Price Behavior Insights: ⢠Neutral momentum ⢠Tight consolidation ⢠Clear stop reference Support Level: $8.90 Resistance Level: $9.90â$9.95 Over the last month FTRE has traded flat around the last-month SMA near $9.46, consolidating above support ~$8.90 with resistance at ~$9.90â$9.95âindicating range-bound action unless a clear breakout or breakdown occurs while it remains well below JanuaryâFebruary peaks (~$16â$17.5).
Sentiment & News
Key News Insights: ⢠Institutional selling ⢠RSU hiring incentive ⢠March concentration Institutional investors sharply trimmed FTRE positions in March while the company granted 130,000 RSUs to new hires, signalling simultaneous external selling pressure and internal talent-focused equity incentives.
AI Summary
Fortrea has shifted from a growth/multiple story to a cashâandâdeleveraging replayâequity upside now hinges on sustaining positive FCF, converting deferred revenue/backlog at stable gross margins, and materially reducing net debt over 12â18 months. Key risk: high leverage and subâ1 current ratio mean any slip in cash conversion, missed EBITDA targets, or a major client slowdown would likely force dilutive financing or a sharp equity reârating.
Description
Fortrea Holdings Inc. is a contract research organization that provides development services for biopharmaceuticals and medical devices globally. Its operations are organized into Clinical Services, covering clinical pharmacology and the spectrum of clinical development, and Enabling Services, which supplies patient access, trial technology, randomization and drug supply support. The company delivers these capabilities through full-service, functional service provider and hybrid models and also offers phase IâIV trial management and post-approval support; it was incorporated in 2023 and is based in Durham, North Carolina.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 4 | Dec 11 | FTRE | Fortrea Holdings Inc. | Fortrea displays strong operational momentum with raised revenue and backlog, cost savings, debt reductions, and a significant 50% rally in 3 weeks; however, margin compression, leverage, legal risk, and overextension temper conviction, requiring active risk management. | Closed | +7.2% |